Your session is about to expire
← Back to Search
Low-vision rehabilitation program for Low Vision
N/A
Waitlist Available
Led By Monali Malvankar
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline up to 24 weeks
Awards & highlights
Study Summary
To evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP).
Eligible Conditions
- Low Vision
- Low Vision Aids
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline up to 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline up to 24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Health related Quality of Life (HRQoL)
Secondary outcome measures
Change in Anxiety Score
Change in Depression Score
Change in Low vision Score
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Low-vision rehabilitation programActive Control1 Intervention
Participants and their care givers in Low-vision rehabilitation program will undergo a standardized interview to measure HRQoL using the time trade-off method (TTO), depression using the Patient Health Questionnaire (PHQ-9), anxiety using Generalized Anxiety Disorder (GAD-7) and Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48) at the first study visit and after Low-vision rehabilitation program.
Group II: No InterventionPlacebo Group1 Intervention
Participants and their care givers will undergo a standardized interview to measure HRQoL using the time trade-off method (TTO), depression using the Patient Health Questionnaire (PHQ-9), anxiety using Generalized Anxiety Disorder (GAD-7) and Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48) at the first study visit and will continue to receive treatment as usual.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,582 Total Patients Enrolled
Monali MalvankarPrincipal InvestigatorWestern University, Canada
3 Previous Clinical Trials
635 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger